Mail Icon info@synchemia.com | sales@synchemia.com Phone Icon 9766925136
We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock
search icon
Mail Icon info@synchemia.com | sales@synchemia.com Phone Icon 9766925136
We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock

Menu

search icon
home icon Home > API Impurities > Nitroso > 4-nitrosomethylaminopyridine

4-nitrosomethylaminopyridine

Chemical Structure
Specifications
Product name
4-nitrosomethylaminopyridine
SRC CAT No
SRC-N014070
CAS No
16219-99-1
Mol.F.
C6H7N3O
Mol.Wt.
137.1g/mol
Related CAS No.
NA
Inv Status
IN STOCK
Chemical Structure
Chemical Structure
view file icon VIEW COA
Product Overview
Description
Chemical Name
4-nitrosomethylaminopyridine

HSN Code
38229010
Synonym
N.A

Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. 4-nitrosomethylaminopyridine can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Nitrosamines . 4-nitrosomethylaminopyridine is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.

4-nitrosomethylaminopyridine chemically represented as 4-nitrosomethylaminopyridine .Synchemia is the leading manufacturing and exporter of 4-nitrosomethylaminopyridine . We supply 4-nitrosomethylaminopyridine with detailed characterization data compliance with regulatory guidelines.